
AngioScore closes $15mm Series B round
Executive Summary
Interventional cardiology company AngioScore closed its $15mm Series B round co-led by Psilos Group Management and California Technology Ventures. Additional new investors Innomed Ventures (owned by Jerusalem Global Ventures), UV Partners, and Linkagene also participated.
Deal Industry
- Medical Devices
-
Medical Devices
-
Surgical Equipment & Devices
- Minimally or Less Invasive
-
Surgical Equipment & Devices
Deal Status
- Final
Deal Type
-
Financing
- Venture Financing
Questions?
Please contact Sales at: (212) 520-2765 or email PharmaNewsSales@informa.com